We’ve entered what we call the Genesis Phase — the point where the idea becomes real work.
Right now, we’re building the foundation. Not the flashy parts, not the things people see first, but the core systems everything else will depend on. Infrastructure, APIs, distributed architecture — the kind of work that decides whether something survives at scale or falls apart later.
We’re still early, about 7% in. And that’s intentional. This stage isn’t about speed, it’s about getting things right.
The problem we’re trying to solve isn’t small. Human longevity today is fragmented — data is scattered, insights are reactive, and systems don’t connect. We’re building something different. A system that can understand biology as a whole, not in isolated pieces.
Once the foundation is ready, the next layer begins. AI models trained on biological data — genomics, biomarkers, real-world health signals. Not just to analyze, but to recognize patterns over time and generate meaningful insight.
Alongside that, we’ll start integrating data streams into a unified system. The goal is simple in theory but difficult in execution: to connect the dots inside the human body in a way that actually makes sense.
Everything we build will be grounded in science. That means validation, research partnerships, and real-world testing. If it can’t be verified, it doesn’t belong here.
This isn’t about chasing trends or shipping fast for the sake of it. It’s about building something that can last — something that changes how we understand health, aging, and the limits of the human body.
We’re at the beginning. And we’re building it properly.